Class information for:
Level 2: ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
617 13940 39.8 71%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
110 3       PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER 71389
617 2             ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA 13940
353 1                   OLANZAPINE//WEIGHT GAIN//ANTIPSYCHOTICS 3605
1348 1                   AMISULPRIDE//ANTIPSYCHOTICS//CLOZAPINE 2704
3230 1                   PALIPERIDONE PALMITATE//LONG ACTING INJECTABLE//LONG ACTING INJECTION 2032
7609 1                   9 HYDROXYRISPERIDONE//NORCLOZAPINE//CLOZAPINE 1348
7852 1                   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY//CHILDHOOD ONSET SCHIZOPHRENIA//PREMORBID DEVELOPMENT 1320
12327 1                   ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE 914
14377 1                   COCHRANE IZOPHRENIA GRP//ACUTE AGITATION//SCHIZOPHRENIA DRUG THERAPY 773
20379 1                   AGRANULOCYTOSIS//CLOZAPINE//CLOZAPINE INDUCED AGRANULOCYTOSIS 463
20744 1                   ASENAPINE//ZIPRASIDONE//LURASIDONE 447
30734 1                   ACID SUPPRESSANT THERAPY//ADVERSE EFFECT OF A DRUG//BIOANAL SECT 164
33986 1                   VENOUS THROMBOSIS AND EMBOLISM//ADULT PY IAT//ANTIDEPRESSANT CLASS 118
37646 1                   HYPERRENEXIA//INJECTABLE RESPERIDONE//MENTAL HLTH MENTAL RETARDAT 52

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 ANTIPSYCHOTICS authKW 1046360 11% 32% 1508
2 CLOZAPINE authKW 818544 7% 38% 995
3 SCHIZOPHRENIA authKW 785964 25% 10% 3518
4 OLANZAPINE authKW 747919 6% 42% 808
5 RISPERIDONE authKW 605166 5% 38% 720
6 PSYCHIATRY WoSSC 459810 65% 2% 9027
7 ATYPICAL ANTIPSYCHOTICS authKW 452514 4% 40% 522
8 ARIPIPRAZOLE authKW 353915 3% 44% 369
9 ANTIPSYCHOTIC AGENTS authKW 234829 2% 42% 256
10 ZIPRASIDONE authKW 231628 1% 54% 195

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 Psychiatry 459810 65% 2% 9027
2 Pharmacology & Pharmacy 36250 31% 0% 4315
3 Psychology, Clinical 9358 6% 1% 868
4 Clinical Neurology 8763 12% 0% 1706
5 Health Policy & Services 7883 4% 1% 579
6 Neurosciences 4321 13% 0% 1756
7 Nursing 1898 2% 0% 340
8 Psychology 1376 3% 0% 369
9 Medicine, General & Internal 1208 6% 0% 840
10 Public, Environmental & Occupational Health 1075 5% 0% 698

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 PSYCHIAT 184853 30% 2% 4118
2 COCHRANE IZOPHRENIA GRP 56172 0% 55% 47
3 IZOPHRENIA PROGRAM 41134 1% 21% 89
4 ZUCKER HILLSIDE HOSP 31532 0% 23% 62
5 PSYCHOSIS SERV 29167 0% 67% 20
6 ANTIPSYCHOT 27351 0% 83% 15
7 UNIV PSYCHIAT 23442 1% 11% 98
8 MED AFFAIRS EMEA 21750 0% 76% 13
9 GERIATR MENTAL HLTH PROGRAM 21211 0% 29% 34
10 EARLY PSYCHOSIS PROGRAMME 19894 0% 91% 10

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 JOURNAL OF CLINICAL PSYCHIATRY 159613 5% 10% 720
2 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 94764 2% 13% 343
3 JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 90999 2% 18% 230
4 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 80887 2% 14% 261
5 SCHIZOPHRENIA RESEARCH 66220 3% 7% 422
6 PSYCHIATRIC SERVICES 53153 2% 8% 316
7 PSYCHOPHARMAKOTHERAPIE 53111 1% 22% 110
8 PHARMACOPSYCHIATRY 44707 1% 10% 203
9 SCHIZOPHRENIA BULLETIN 33692 2% 7% 210
10 INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 31289 1% 13% 108

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
LCSH search Wikipedia search
1 ANTIPSYCHOTICS 1046360 11% 32% 1508 Search ANTIPSYCHOTICS Search ANTIPSYCHOTICS
2 CLOZAPINE 818544 7% 38% 995 Search CLOZAPINE Search CLOZAPINE
3 SCHIZOPHRENIA 785964 25% 10% 3518 Search SCHIZOPHRENIA Search SCHIZOPHRENIA
4 OLANZAPINE 747919 6% 42% 808 Search OLANZAPINE Search OLANZAPINE
5 RISPERIDONE 605166 5% 38% 720 Search RISPERIDONE Search RISPERIDONE
6 ATYPICAL ANTIPSYCHOTICS 452514 4% 40% 522 Search ATYPICAL+ANTIPSYCHOTICS Search ATYPICAL+ANTIPSYCHOTICS
7 ARIPIPRAZOLE 353915 3% 44% 369 Search ARIPIPRAZOLE Search ARIPIPRAZOLE
8 ANTIPSYCHOTIC AGENTS 234829 2% 42% 256 Search ANTIPSYCHOTIC+AGENTS Search ANTIPSYCHOTIC+AGENTS
9 ZIPRASIDONE 231628 1% 54% 195 Search ZIPRASIDONE Search ZIPRASIDONE
10 QUETIAPINE 196032 2% 31% 285 Search QUETIAPINE Search QUETIAPINE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 HASAN, A , FALKAI, P , WOBROCK, T , LIEBERMAN, J , GLENTHOJ, B , GATTAZ, WF , THIBAUT, F , MOLLER, HJ , (2012) WORLD FEDERATION OF SOCIETIES OF BIOLOGICAL PSYCHIATRY (WFSBP) GUIDELINES FOR BIOLOGICAL TREATMENT OF SCHIZOPHRENIA, PART 1: UPDATE 2012 ON THE ACUTE TREATMENT OF SCHIZOPHRENIA AND THE MANAGEMENT OF TREATMENT RESISTANCE.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. VOL. 13. ISSUE 5. P. 318 -378 381 77% 86
2 BAK, M , FRANSEN, A , JANSSEN, J , VAN OS, J , DRUKKER, M , (2014) ALMOST ALL ANTIPSYCHOTICS RESULT IN WEIGHT GAIN: A META-ANALYSIS.PLOS ONE. VOL. 9. ISSUE 4. P. - 236 72% 38
3 BARNES, TRE , (2011) EVIDENCE-BASED GUIDELINES FOR THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: RECOMMENDATIONS FROM THE BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 25. ISSUE 5. P. 567 -620 323 54% 109
4 HASAN, A , FALKAI, P , WOBROCK, T , LIEBERMAN, J , GLENTHOJ, B , GATTAZ, WF , THIBAUT, F , MOLLER, HJ , (2013) WORLD FEDERATION OF SOCIETIES OF BIOLOGICAL PSYCHIATRY (WFSBP) GUIDELINES FOR BIOLOGICAL TREATMENT OF SCHIZOPHRENIA, PART 2: UPDATE 2012 ON THE LONG-TERM TREATMENT OF SCHIZOPHRENIA AND MANAGEMENT OF ANTIPSYCHOTIC-INDUCED SIDE EFFECTS.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. VOL. 14. ISSUE 1. P. 2-44 186 70% 82
5 NEWCOMER, JW , (2005) SECOND-GENERATION (ATYPICAL) ANTIPSYCHOTICS AND METABOLIC EFFECTS - A COMPREHENSIVE LITERATURE REVIEW.CNS DRUGS. VOL. 19. ISSUE . P. 1 -93 140 71% 809
6 DE HERT, M , CORRELL, CU , BOBES, J , CETKOVICH-BAKMAS, M , COHEN, D , ASAI, I , DETRAUX, J , GAUTAM, S , MOLLER, HJ , NDETEI, DM , ET AL (2011) PHYSICAL ILLNESS IN PATIENTS WITH SEVERE MENTAL DISORDERS. I. PREVALENCE, IMPACT OF MEDICATIONS AND DISPARITIES IN HEALTH CARE.WORLD PSYCHIATRY. VOL. 10. ISSUE 1. P. 52 -77 199 42% 339
7 RAGGI, MA , MANDRIOLI, R , SABBIONI, C , PUCCI, V , (2004) ATYPICAL ANTIPSYCHOTICS: PHARMACOKINETICS, THERAPEUTIC DRUG MONITORING AND PHARMACOLOGICAL INTERACTIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 3. P. 279-296 190 85% 66
8 GALLEGO, JA , BONETTI, J , ZHANG, JP , KANE, JM , CORRELL, CU , (2012) PREVALENCE AND CORRELATES OF ANTIPSYCHOTIC POLYPHARMACY: A SYSTEMATIC REVIEW AND META-REGRESSION OF GLOBAL AND REGIONAL TRENDS FROM THE 1970S TO 2009.SCHIZOPHRENIA RESEARCH. VOL. 138. ISSUE 1. P. 18-28 127 89% 50
9 VANCAMPFORT, D , WAMPERS, M , MITCHELL, AJ , CORRELL, CU , DE HERDT, A , PROBST, M , DE HERT, M , (2013) A META-ANALYSIS OF CARDIO-METABOLIC ABNORMALITIES IN DRUG NAIVE, FIRST-EPISODE AND MULTI-EPISODE PATIENTS WITH SCHIZOPHRENIA VERSUS GENERAL POPULATION CONTROLS.WORLD PSYCHIATRY. VOL. 12. ISSUE 3. P. 240-250 125 85% 39
10 KRUSE, G , WONG, BJO , DUH, MS , LEFEBVRE, P , LAFEUILLE, MH , FASTENAU, JM , (2015) SYSTEMATIC LITERATURE REVIEW OF THE METHODS USED TO COMPARE NEWER SECOND-GENERATION AGENTS FOR THE MANAGEMENT OF SCHIZOPHRENIA: A FOCUS ON HEALTH TECHNOLOGY ASSESSMENT.PHARMACOECONOMICS. VOL. 33. ISSUE 10. P. 1049 -1067 148 78% 0

Classes with closest relation at Level 2



Rank Class id link
1 2247 TARDIVE DYSKINESIA//AKATHISIA//VACUOUS CHEWING MOVEMENTS
2 81 SCHIZOPHRENIA//SCHIZOPHRENIA RESEARCH//PSYCHIATRY
3 396 PSYCHIATRIC REHABILITATION JOURNAL//PSYCHIATRY//HOSPITAL AND COMMUNITY PSYCHIATRY
4 400 BIPOLAR DISORDER//JOURNAL OF AFFECTIVE DISORDERS//PSYCHIATRY
5 3387 DIMEBON//REMOXIPRIDE//LATREPIRDINE
6 2358 ELECTROCONVULSIVE THERAPY//JOURNAL OF ECT//CONVULSIVE THERAPY
7 1352 SECLUSION//WORKPLACE VIOLENCE//INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY
8 1266 PREMATURE EJACULATION//FEMALE SEXUAL DYSFUNCTION//SEXUAL DYSFUNCTION
9 2761 CANAVAN DISEASE//N ACETYLASPARTYLGLUTAMATE//N ACETYLASPARTATE
10 207 PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION

Go to start page